1. Home
  2. ALT vs FRA Comparison

ALT vs FRA Comparison

Compare ALT & FRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Altimmune Inc.

ALT

Altimmune Inc.

N/A

Current Price

$1.45

Market Cap

377.4M

Sector

Health Care

ML Signal

N/A

Logo Blackrock Floating Rate Income Strategies Fund Inc

FRA

Blackrock Floating Rate Income Strategies Fund Inc

N/A

Current Price

$9.97

Market Cap

367.5M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ALT
FRA
Founded
1997
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
377.4M
367.5M
IPO Year
2005
2003

Fundamental Metrics

Financial Performance
Metric
ALT
FRA
Price
$1.45
$9.97
Analyst Decision
Strong Buy
Analyst Count
10
0
Target Price
★ $16.33
N/A
AVG Volume (30 Days)
★ 3.8M
167.3K
Earning Date
11-12-2026
01-01-0001
Dividend Yield
N/A
★ 11.06%
EPS Growth
★ 25.37
N/A
EPS
N/A
★ N/A
Revenue
★ $41,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 105.00
N/A
52 Week Low
$1.50
$9.65
52 Week High
$6.44
$12.23

Technical Indicators

Market Signals
Indicator
ALT
FRA
Relative Strength Index (RSI) 21.10 38.51
Support Level N/A $9.65
Resistance Level $3.35 $11.20
Average True Range (ATR) 0.14 0.12
MACD -0.03 -0.01
Stochastic Oscillator 1.26 4.60

Price Performance

Historical Comparison
ALT
FRA

About ALT Altimmune Inc.

Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's key candidate, pemvidutide, is a dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About FRA Blackrock Floating Rate Income Strategies Fund Inc

Blackrock Floating Rate Inc Stra Fd Inc is a closed-end management investment company. Its investment objective is to provide shareholders with high current income and such preservation of capital as is consistent with investment in a diversified, leveraged portfolio consisting of floating rate debt securities and instruments. The Fund seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its managed assets in floating rate debt securities, including floating or variable rate debt securities that pay interest at rates that adjust whenever a specified interest rate changes and/or which reset on predetermined dates (such as the last day of a month or calendar quarter).

Share on Social Networks: